John Josey, PhD
InvestorPartner at The Column Group
Find your path to John
29 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Tim KutzkeyunlockedJohn: together at The Column Group
×11John: together at The Column Group
About
John Josey is a scientist and repeat biotech CEO with PhD in organic chemistry, active medicinal chemistry publications, hands-on drug discovery, and he led Peloton Therapeutics to acquisition by Merck.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
David Goeddel
Managing Partner at The Column Group
David V. Goeddel, Ph.D.
General Partner at The Column Group
David V. Goeddel, PhD
Partner Emeritus at The Column Group
Hui Tian
Partner at The Column Group
Frequently asked questions
- Who is John Josey, PhD?
- John Josey is a scientist and repeat biotech CEO with PhD in organic chemistry, active medicinal chemistry publications, hands-on drug discovery, and he led Peloton Therapeutics to acquisition by Merck.
- Where does John Josey, PhD work?
- John Josey, PhD is Partner at The Column Group.
- What does John Josey, PhD invest in?
- John Josey, PhD invests in Biotech, Healthtech.